On March 19, 2026, GSK plc purchased 650,000 of its ordinary shares at a volume-weighted average price of 1,954.04 pence, part of its ongoing buyback program. Following this purchase, GSK holds 252,662,615 shares in treasury out of a total of 4,063,508,150 shares issued.